Følg
nordin hanssen
nordin hanssen
Amsterdam UMC
Verifisert e-postadresse på amsterdamumc.nl
Tittel
Sitert av
Sitert av
År
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
P De Groot, T Nikolic, S Pellegrini, V Sordi, S Imangaliyev, E Rampanelli, ...
Gut 70 (1), 92-105, 2021
2812021
Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype
NMJ Hanssen, K Wouters, MS Huijberts, MJ Gijbels, JC Sluimer, ...
European heart journal 35 (17), 1137-1146, 2014
2232014
Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes
MJ Kraakman, MKS Lee, A Al-Sharea, D Dragoljevic, TJ Barrett, ...
The Journal of clinical investigation 127 (6), 2133-2147, 2017
2082017
Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study
JLJM Scheijen, NMJ Hanssen, MM Van Greevenbroek, CJ Van der Kallen, ...
Clinical nutrition 37 (3), 919-925, 2018
1682018
Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 …
NMJ Hanssen, JWJ Beulens, S Van Dieren, JLJM Scheijen, DL Van Der A, ...
Diabetes 64 (1), 257-265, 2015
1592015
Fecal microbiota transplantation in human metabolic diseases: from a murky past to a bright future?
NMJ Hanssen, WM de Vos, M Nieuwdorp
Cell Metabolism 33 (6), 1098-1110, 2021
1472021
Plasma Levels of Advanced Glycation Endproducts Nϵ-(carboxymethyl)lysine, Nϵ-(carboxyethyl)lysine, and Pentosidine Are not Independently Associated With …
NMJ Hanssen, L Engelen, I Ferreira, JLJM Scheijen, MS Huijberts, ...
The Journal of Clinical Endocrinology & Metabolism 98 (8), E1369-E1373, 2013
1362013
Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to …
Z Mujagic, S Ludidi, D Keszthelyi, MAM Hesselink, JW Kruimel, ...
Alimentary pharmacology & therapeutics 40 (3), 288-297, 2014
1342014
Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesis
MC Flynn, MJ Kraakman, C Tikellis, MKS Lee, NMJ Hanssen, ...
Circulation research 127 (7), 877-892, 2020
1252020
l (+) and d (−) lactate are increased in plasma and urine samples of type 2 diabetes as measured by a simultaneous quantification of l (+) and d (−) lactate by reversed‐phase …
JLJM Scheijen, NMJ Hanssen, MPH Waarenburg, DMAE Jonkers, ...
Journal of Diabetes Research 2012 (1), 234812, 2012
1062012
Post–glucose load plasma α-dicarbonyl concentrations are increased in individuals with impaired glucose metabolism and type 2 diabetes: the CODAM study
DE Maessen, NM Hanssen, JL Scheijen, CJ van der Kallen, ...
Diabetes Care 38 (5), 913-920, 2015
1012015
Higher plasma methylglyoxal levels are associated with incident cardiovascular disease and mortality in individuals with type 2 diabetes
NMJ Hanssen, J Westerink, JLJM Scheijen, Y Van Der Graaf, ...
Diabetes care 41 (8), 1689-1695, 2018
922018
Higher plasma methylglyoxal levels are associated with incident cardiovascular disease in individuals with type 1 diabetes: a 12-year follow-up study
NMJ Hanssen, JLJM Scheijen, A Jorsal, HH Parving, L Tarnow, ...
Diabetes 66 (8), 2278-2283, 2017
922017
The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1
MGA Van Eupen, MT Schram, HM Colhoun, NMJ Hanssen, ...
Diabetologia 56, 1845-1855, 2013
722013
Associations between the ankle-brachial index and cardiovascular and all-cause mortality are similar in individuals without and with type 2 diabetes: nineteen-year follow-up of …
NMJ Hanssen, MS Huijberts, CG Schalkwijk, G Nijpels, JM Dekker, ...
Diabetes care 35 (8), 1731-1735, 2012
692012
Interactions between tryptophan metabolism, the gut microbiome and the immune system as potential drivers of non-alcoholic fatty liver disease (NAFLD) and metabolic diseases
C Teunis, M Nieuwdorp, N Hanssen
Metabolites 12 (6), 514, 2022
652022
Quercetin, but not epicatechin, decreases plasma concentrations of methylglyoxal in adults in a randomized, double-blind, placebo-controlled, crossover trial with pure flavonoids
MDG Van den Eynde, JM Geleijnse, JLJM Scheijen, NMJ Hanssen, ...
The Journal of nutrition 148 (12), 1911-1916, 2018
632018
Methylglyoxal and glyoxalase I in atherosclerosis
NMJ Hanssen, CDA Stehouwer, CG Schalkwijk
Biochemical Society Transactions 42 (2), 443-449, 2014
612014
Methylglyoxal and advanced glycation end products in patients with diabetes–what we know so far and the missing links
JB Groener, D Oikonomou, R Cheko, Z Kender, J Zemva, L Kihm, ...
Experimental and Clinical Endocrinology & Diabetes 127 (08), 497-504, 2019
602019
Postprandial glucose spikes, an important contributor to cardiovascular disease in diabetes?
NMJ Hanssen, MJ Kraakman, MC Flynn, PR Nagareddy, CG Schalkwijk, ...
Frontiers in cardiovascular medicine 7, 570553, 2020
592020
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20